Our findings revealed that high levels of tumor B7-H3 are associated with poorer survival outcomes in patients with colon adenocarcinoma (COAD), especially in high-risk COAD patients who have received postoperative chemotherapy. Here, CD276 is linked to colon adenocarcinoma.